<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="204877">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00421902</url>
  </required_header>
  <id_info>
    <org_study_id>NYM # 325</org_study_id>
    <nct_id>NCT00421902</nct_id>
  </id_info>
  <brief_title>Acupuncture Treatment for Hot Flashes Study</brief_title>
  <official_title>Acupuncture Treatment for Hot Flashes in Men With Prostate Cancer, A Phase I/II Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York Methodist Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York Methodist Hospital</source>
  <brief_summary>
    <textblock>
      Patients with prostate cancer who are / were treated with hormonal treatment and developed
      hot flashes as a side effect are offered Acupuncture as an investigational intervention. The
      treatment is performed twice a week for four weeks, then once a week for the following six
      weeks
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2006</start_date>
  <completion_date>July 2010</completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relief from the hot flashes as determined by the hot flashes scoring system.</measure>
  </primary_outcome>
  <enrollment>50</enrollment>
  <condition>Prostate Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Treatment for prostate cancer using hormonal ablation therapy

          -  Average of three or more hot flashes a day

          -  Performance Status (Karnofsky ≥ 60)

          -  Patients must be ≥ 18 years of age

          -  No other clinically significant disease

          -  Signed study-specific consent form prior to study entry

        Exclusion Criteria:

          -  Initiation of a new chemotherapy regimen, immunotherapy; or initiation/ cessation of
             hormonal therapy during the study or for 3 weeks before the start of the study

          -  Pharmacological treatment of hot flashes or use of selective serotonin reuptake
             inhibitors (unless the dose and patients’ condition have been stable for 4 weeks)

          -  Skin infections

          -  Patients who had acupuncture treatment in the 6 weeks prior to entering the study, or
             acupuncture given specifically for the treatment of hot flashes in the previous 6
             months.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hani Ashamalla, MD, FCCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>NY Methodist Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adel Guirguis, MD, MS</last_name>
    <role>Study Director</role>
    <affiliation>NY Methodist Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hani Ashamalla, MD, FCCP</last_name>
    <phone>718 780 3677</phone>
    <email>hashamalla@aol.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adel Guirguis, MD, MS</last_name>
    <phone>718 780 3677</phone>
    <email>adg9003@nyo.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NY Methodist Hospital</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adel Guirguis, MD, MS</last_name>
      <phone>718-780-3677</phone>
      <email>adg9003@nyp.org</email>
    </contact>
    <investigator>
      <last_name>Hani Ashamalla, MD, FCCP</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francis Florio, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bahaa Mokhtar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2006</verification_date>
  <lastchanged_date>January 12, 2007</lastchanged_date>
  <firstreceived_date>January 12, 2007</firstreceived_date>
  <keyword>Hot flashes, prostate cancer, acupuncture</keyword>
  <keyword>Prostate cancer patients with hot flashes due to their hormonal treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
    <mesh_term>Hot Flashes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
